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Introduction: The rare variant of renal epithelioid/pleomorphic angiomyolipoma has been reported in
approximately 120 cases. One of the most important characteristics to differentiate these tumors from other renal
cell neoplasms is their typical reactivity to premelanosome antigens. If such a tumor does not stain for HMB-45 or
Melan-A, a specific diagnosis of epithelioid/pleomorphic angiomyolipoma cannot be made with certainty.
Case presentation: We present here what is, to the best of our knowledge, the first case of epithelioid/
pleomorphic angiomyolipoma of the kidney in a 50-year-old Caucasian man with no history of tuberous sclerosis,
and with a tumor marker profile negative for several premelanosome antigens. The tumor was composed of sheets
of pleomorphic, round to polygonal epithelioid cells with prominent eosinophilic cytoplasm, large nuclei, many
multinucleated, and very prominent nucleoli. There were prominent vessels and rare interspersed smooth muscle
fibers, but adipocytes were not identified. A tumor marker profile showed tumor cell reactivity for CD68, calponin
and focally for CD10. Intervening smooth muscle was reactive with smooth muscle actin. The tumor lacked
reactivity for melanin-associated antigens HMB-45 and Melan-A, and for CD31, pan-cytokeratin (AE1/3) and desmin.
Electron microscopic examination of tumor cells confirmed the presence of premelanosome-like granules.
Conclusions: Based on the characteristic microscopic appearance of this tumor, and its overall tumor marker
profile, we concluded this was a renal epithelioid/pleomorphic angiomyolipoma with a negative premelanosome
antigen phenotype.Introduction
Angiomyolipomas (AML) are members of a family of tu-
mors derived from mesenchymal, perivascular epithelioid
cells, normally clustered around blood vessels, and usually
named PEComas (for ‘perivascular epithelioid cell tumors’).
Renal AML contain varying amounts of three major histo-
logical components: blood vessels, smooth muscle, and
adipose tissue. AML comprises 2.0 percent to 6.4 percent
of all renal tumors and is most commonly benign in beha-
vior [1]. AML can occur as an isolated lesion or as part of
the tuberous sclerosis complex (45 percent of cases).
Rare cases of AML, composed of a prominent epithelioid
component, with spindle and giant cells, containing none* Correspondence: Francisco.LaRosa@ucdenver.edu
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reproduction in any medium, provided the oror a minimal amount of adipose tissue, have been reported
as the epithelioid variant of angiomyolipoma (EAML) [2].
Up to one-third of these variants show a more aggressive
or malignant clinical behavior, yet their overall prognosis
has not been clearly defined [1,3]. The epithelioid cells in
EAML can be quite pleomorphic and the appearance of a
carcinoma-like pattern is frequently observed. Additional
focal necrosis, hemorrhage, increased mitotic activity and
larger sizes are usually correlated with more aggressive,
malignant behavior. These features might lead to an erro-
neous diagnosis of high-grade renal cell carcinoma, par-
ticularly since intra-tumoral fat can occur in these tumors
[4]. In the approximately 120 reported cases of renal
EAML, the presence of premelanosome antigens (PMA)
has been used as one of the main diagnostic landmarks
[1,3]. This is in addition to the expression of some other
important markers such as calponin and CD68, and theral Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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cytokeratin AE1/AE3, high molecular weight cytokeratin
and CAM5.2 [5]. Thus, if such a tumor does not stain for
HMB-45 or Melan-A, a specific diagnosis of EAML cannot
be made with certainty. We report here a rare case of a
7cm renal tumor in a 50-year-old man, which we classify
as a renal EAML despite its negative PMA phenotype.
Case presentation
Our patient was a 50-year-old Caucasian man with a me-
dical history significant for hypertension, obesity, and
nephrolithiasis, and no history of tuberous sclerosis, who
presented to our facility with a five-day history of fever,
chills, night sweats and lethargy. He had intentionally lost
just over 9kg (20 pounds) while taking a product called
‘Healthy Trim’ during the previous month, but had
stopped taking it approximately one week prior to presen-
tation. Initial laboratory test results included only a mild
normochromic normocytic anemia and an increased
erythrosedimentation rate of 86mm/hour. A chest X-ray
showed clear lungs with no evidence of consolidation,
pleural effusion or pneumothorax; his heart was of normal
size.
His symptoms continued and approximately two
weeks later a chest, abdomen and pelvis computed tom-
ography (CT) scan was performed. This imaging study
showed a solid heterogeneous mass (73×66×65mm) in-Figure 1 Left kidney mass. (A) Computed tomography scan showing a h
73×66×65mm across its maximal dimensions (crossing yellow bars). (B) Mic
variant of angiomyolipoma tumor showing sheets of pleomorphic, round t
large nuclei, many of them multinucleated, and with very prominent nucle
adipocytes were identified (40× objective). Microscopic images from the re
showing positive reactivity for calponin (C), CD68 (D), smooth muscle actinvolving the parenchyma of the upper pole of the left kid-
ney (Figure 1A). It extended exophytically from the su-
perior and posterior-medial aspects of the kidney. No
renal vein invasion or regional lymph node enlargement
was detected. The right kidney showed a 35mm simple,
homogeneous cystic formation with no evidence of solid
component; no other solid renal masses were identified.
Our patient underwent a hand-assisted laparoscopic
left nephrectomy with adrenalectomy without compli-
cations. Hand-assisted laparoscopic nephrectomies are
performed per our institution’s protocol in all cases of
renal tumors to avoid morcellation and to maintain the
integrity of the specimen. After surgery, a gross surgical
pathology examination revealed a 19×8×6.5cm left kid-
ney with a 3.5×1×1cm adrenal gland. The external sur-
face of the specimen was inked black and the specimen
was then bi-valved, revealing a 7.5×5.1×4.0cm pinkish/
tan, extremely friable and necrotic mass located in the
superior pole of the kidney. The mass appeared well
circumscribed with pushing borders that displaced, but
appeared to not invade, into the superior peri-renal adi-
pose tissue. The inferior portion of the mass involved
the renal pelvis. The mass extended to 0.1cm from the
superior margin and 4.5cm from the renal vein margin;
no tumor thrombus in the renal vein was present. The
uninvolved renal tissue showed a well-defined cortico-
medullary junction with an average cortical thickness ofeterogeneous hypo-dense mass in the left kidney measuring
roscopic image from hematoxylin and eosin sections of the epithelioid
o polygonal epithelioid cells, with prominent eosinophilic cytoplasm,
oli; some interspersed smooth muscle fibers were present but no
nal epithelioid angiomyolipoma with immunoperoxidase stainings
(E), and negative reactivity for HMB45 (F) (all at 40× objective).
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calculus in the inferior pole. The adrenal gland was grossly
unremarkable with no lesions identified. Representative
sections were submitted for histological preparations.
Histologically, sections of the mass showed round pleo-
morphic and occasionally multinucleated tumor cells with
eosinophilic cytoplasm, macronucleoli, and rare mitotic
figures; moderate interspersed smooth muscle fibers were
observed, but adipocytes were not identified (Figure 1B).
There was prominent vasculature, focal necrosis and
hemorrhage; a microfocus of tumor invasion into the peri-
renal adipose tissue was present with no invasion beyond
Gerota’s fascia. No regional lymph nodes were identified.
The Pathologic Staging pTNM of the tumor was pT3a,
Nx, Mx (Stage III).
Immunoperoxidase stainings showed tumor cells with
uniform cytoplasmic reactivity for vimentin, calponin
(Figure 1C), and CD68 (Figure 1D). The tumor cells had
patchy reactivity for CD10 and epithelial membrane
antigen (EMA). Smooth muscle actin (SMA) stained
only the intervening smooth muscle slips and small
round capillaries (Figure 1E). Immunostaining for HMB-
45 (Figure 1F) and Melan-A were performed on two
separate areas of the tumor and using two different
chromogens, diaminobenzidine (DAB) and alkaline
phosphatase (AP), and all showed negative staining of
the tumor cells. Negative stainings were also observed
for renal cell carcinoma (RCC) antigen, cytokeratin AE1/
AE3, cytokeratin 7, high molecular weight cytokeratin
(MA903), CAM5.2, CD1, CD31, CD117, S100,
microphthalmia-associated transcription factor (MiTF),
tyrosinase (DBA and AP), and desmin (only blood ves-
sels were positive). Staining for Ki-67 (MIB-1) was
performed to evaluate the proliferative activity of the
tumor, which showed positive nuclear staining in an
average of approximately 30 percent of the tumor cells.
The positive and negative controls reacted appropriately
for each staining.Figure 2 Electron microscopic image of renal epithelioid angiomy
premelanosomes, similar to those reported previously [6].Tissue retrieved from a paraffin block was subjected to
electron microscopic examination in an attempt to dem-
onstrate the premelanosome-like granules that are usually
present in epithelioid angiomyolipoma cells. While the
paraffin sample used for this study provided suboptimal
tissue fixation, we were able to identify tumor cells with
finely granular organelles with a substructural periodicity
resembling that of premelanosomes (Figure 2) [6].
In the 26 months of clinical follow-up data available at
the time of submission of this report, four chest/abdomen/
pelvis CT scans were performed, none of which demon-
strated evidence of local recurrence or metastatic disease.
Our patient did not receive chemotherapy or radiation
therapy.
Discussion
Renal EAMLs are rare neoplasms with approximately 120
cases reported in the literature [3]. After the discovery of
AML’s association with HMB-45 in 1991, reports of
EAMLs began to appear in the literature [1-5]. In 2009,
Tsai et al. published five cases from their practice within
the previous 10 years and summarized 17 other cases
from the recent literature [5]. Similar to other case re-
ports, Tsai et al. found that at least half of EAML cases
were associated with the tuberous sclerosis complex, all
contained minimal to no fat and all demonstrated a posi-
tive reaction to PMA [5].
Distant metastases to the lungs from renal EAMLs were
first described in 1991 by Ferry et al. [7]. In that report, the
observed distant metastases were biopsy proven and ultim-
ately fatal. In a recent series review of 33 pure EAML cases,
Nese et al. found local recurrence in 17 percent, metastasis
in almost 50 percent, and death due to disease in appro-
ximately one-third of cases [3]. Conversely, Aydin et al.
followed 15 patients with EAML for a mean of 5.1 years
and none had local recurrence or metastases [1]. Many of
these apparently benign cases had atypical histologic fea-
tures such as coagulative tumor necrosis, nuclear atypiaolipoma cells bearing cytoplasmic organelles consisting of
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morphologic criteria for malignancy in EAMLs have not
been clearly identified [1].
Due to their varying appearances and pleomorphism,
renal EAMLs can pose diagnostic difficulty. Eble et al.
reported five EAML tumors in patients from 20 to 48
years of age and observed that their different microscopic
features resembled other benign or malignant tumors [8].
Spindle-shaped smooth muscle cells, epithelioid cells and
abundant atypism and pleomorphism mimicked leio-
myomas, renal cell carcinomas and leiomyosarcomas [8],
with the additional and paradoxical association of lack of
adipose tissue. Additionally, gross extension into peri-
renal tissue and microscopic entrapment of normal renal
tissue caused suspicion of a more invasive process [8].
Immunohistochemistry was valuable in sorting through
the sometimes lengthy differential diagnoses. Compared
to renal cell carcinomas, renal EAML tumors are distinct-
ively negative for cytokeratin and other epithelial markers,
and positive for PMA, CD68 and calponin. Even though a
few angiolipomas and other PEComas arising in non-renal
locations (that is, liver, lungs, and so on) have been
reported to have patchy or negative reactivity for melano-
some markers, recent reviews consider that 100 percent of
renal EAMLs are positive for either HMB-45 or Melan-A
[5,9-12]. Thus, if they do not stain for HMB-45 or Melan-
A, a specific diagnosis of EAML would require an alterna-
tive approach.
In our patient’s case, we observed tumor cells with
morphological features of EAML both by light and elec-
tron microscopic examination. In addition, tumor cells
showed negative staining for all but one (EMA) of the
conventional renal carcinoma epithelial markers. Even
though the presence of EMA expression in our patient’s
case is quite puzzling; it is generally accepted that aber-
rant antigenic expression of non-organ related antigenic
markers is a fairly common feature in tumor biology.
EMA expression has been reported in many non-epithelial
tumors, even in some lymphomas.
To explain the lack of PMA expression in our patient’s
case, we could use a similar rationale as discussed above
for the aberrant antigenic expression. It is tempting to
speculate that specific mutation(s) of the genes expressing
premelanosome epitopes are missing in our patient’s case,
although specific molecular genetic studies have not been
performed for confirmation. PMA negative expression has
been described even in melanoma cases, and electron
microscopic studies need to be performed to confirm the
presence of premelanosome structures, similar to other
EAML cases reported earlier [6]. Premelanosome-like
structures seen in EAML are not melanized; they usually
have the capacity to produce tyrosinase in approximately
50 percent of cases, which explains their granular appea-
rance, but lack of melanin. Thus, the possibility of unusualimmunophenotypic expression should always be consid-
ered when the morphologic and molecular manifestations
of a tumor are discrepant.
An extended review of the literature has not revealed
a single report of a renal EAML without positivity for at
least one premelanosome marker. Zavala-Pompa et al.
studied 21 classic angiomyolipomas, in which Melan-A
was positive in 18 cases (86 percent), HMB-45 in 16
cases (77 percent), and MiTF in 76 percent. Among
four EAMLs, three were positive for Melan-A, three
were positive for MiTF, but all four were positive for
HMB-45 [13]. Likewise, all other case reports of renal
EAML in which these markers were studied had do-
cumented reactivity for Melan-A and/or HMB-45
[3,5,7,8,10,11].
Management of EAMLs has not been extensively stud-
ied. Surgical resection of these tumors frequently occurs
because they are radiologically mistaken for renal cell
carcinomas and confirmatory biopsies are many times
not performed. Mutations in tuberous sclerosis genes re-
sult in a constitutive activation of the mammalian target
of rapamycin (mTOR) and the drug sirolimus (also
known as rapamycin) suppresses such mTOR signaling.
Thus, sirolimus has reportedly been successfully used in
AMLs [14], as well as in some [15] but not all [16] cases
of other tumors of the PEComa family.
Conclusions
Based on the characteristic microscopic appearance of
this tumor, its overall tumor marker profile and identifi-
cation of premelanosome structures by electron micros-
copy, we conclude that it was a renal EAML with lack of
reactivity for premelanosome markers, a finding that
makes this tumor different from all previously reported
cases.
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